273 related articles for article (PubMed ID: 15233928)
21. Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats.
Li P; Penner SB; Smyth DD
Br J Pharmacol; 1994 May; 112(1):200-6. PubMed ID: 8032642
[TBL] [Abstract][Full Text] [Related]
22. Activation of central α2-adrenoceptors mediates salivary gland vasoconstriction.
Moreira TS; Takakura AC; Menani JV; Colombari E
Arch Oral Biol; 2013 Feb; 58(2):167-73. PubMed ID: 22818538
[TBL] [Abstract][Full Text] [Related]
23. Alpha-adrenergic pathways in the lateral hypothalamus are important for the dipsogenic effect of carbachol injected into the medial septal area.
Callera JC; Saad WA; Camargo LA; Menani JV; Renzi A; Abrão-Saad W
Braz J Med Biol Res; 1995 Feb; 28(2):240-5. PubMed ID: 7581048
[TBL] [Abstract][Full Text] [Related]
24. Central moxonidine on salivary gland blood flow and cardiovascular responses to pilocarpine.
Moreira TS; Takakura AC; Colombari E; De Luca LA; Renzi A; Menani JV
Brain Res; 2003 Oct; 987(2):155-63. PubMed ID: 14499959
[TBL] [Abstract][Full Text] [Related]
25. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
[TBL] [Abstract][Full Text] [Related]
26. Imidazoline receptor mediated natriuresis: central and/or peripheral effect?
Smyth DD; Penner SB
J Auton Nerv Syst; 1998 Oct; 72(2-3):155-62. PubMed ID: 9851564
[TBL] [Abstract][Full Text] [Related]
27. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
28. Moxonidine into the lateral parabrachial nucleus reduces renal and hormonal responses to cell dehydration.
Andrade CA; Margatho LO; Andrade-Franzé GM; De Luca LA; Antunes-Rodrigues J; Menani JV
Neuroscience; 2012 Apr; 208():69-78. PubMed ID: 22373877
[TBL] [Abstract][Full Text] [Related]
29. Apparent absence of direct renal effect of imidazoline receptor agonists.
Smyth DD; Pirnat D; Forzley B; Penner SB
Ann N Y Acad Sci; 2003 Dec; 1009():288-95. PubMed ID: 15028602
[TBL] [Abstract][Full Text] [Related]
30. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
[TBL] [Abstract][Full Text] [Related]
31. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
Evans RG; Anderson WP
Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
[TBL] [Abstract][Full Text] [Related]
32. Imidazoline receptors of the paraventricular nucleus on the pressor response induced by stimulation of the subfornical organ.
Saad WA; Camargo LA; Silveira JE; Saad R; Camargo GM
J Physiol Paris; 1998 Feb; 92(1):25-30. PubMed ID: 9638593
[TBL] [Abstract][Full Text] [Related]
33. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits.
Parkin ML; Godwin SJ; Head GA
J Hypertens; 2003 Jan; 21(1):167-78. PubMed ID: 12544449
[TBL] [Abstract][Full Text] [Related]
34. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
Chan CK; Burke SL; Head GA
J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
[TBL] [Abstract][Full Text] [Related]
35. Effects of moxonidine and clonidine on potassium excretion in Sprague-Dawley rats.
Hohage H; Mehrens T; Matzkies F; Steinmetz M; Greven J
Pharmacol Res; 1999 May; 39(5):357-61. PubMed ID: 10328993
[TBL] [Abstract][Full Text] [Related]
36. Alpha2-adrenoceptor ligands inhibit alpha1-adrenoceptor-mediated contraction of isolated rat arteries.
Artigues-Varin C; Richard V; Varin R; Mulder P; Thuillez C
Fundam Clin Pharmacol; 2002 Aug; 16(4):281-7. PubMed ID: 12570016
[TBL] [Abstract][Full Text] [Related]
37. Effects of the I(1) imidazoline/alpha(2)-adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats.
Shannon HE; Lutz EA
Pain; 2000 Mar; 85(1-2):161-7. PubMed ID: 10692615
[TBL] [Abstract][Full Text] [Related]
38. Sympathoinhibitory action of rilmenidine in conscious sinoaortically denervated rats.
Mayorov D; Chernobelski M; Medvedev O
J Cardiovasc Pharmacol; 1993 Aug; 22(2):314-20. PubMed ID: 7692175
[TBL] [Abstract][Full Text] [Related]
39. [Interaction of rilmenidine with renal imidazoline-guanidine sites].
Lachaud V; Bidet M; Coupry I; Podevin RA; Poujeol P; Parini A
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():15-8. PubMed ID: 2576516
[TBL] [Abstract][Full Text] [Related]
40. Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.
Velliquette RA; Kossover R; Previs SF; Ernsberger P
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):300-12. PubMed ID: 16416266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
